EMEA-000576-PIP02-11-M04 - paediatric investigation plan

Tofacitinib

Key facts

• Active Substance:
  Tofacitinib
• Therapeutic area:
  Dermatology
• Decision number:
  P/0055/2017
• PIP number:
  EMEA-000576-PIP02-11-M04
• Pharmaceutical form(s):
  • Film-coated tablet
  • Oral solution
• Condition(s) / indication(s):
  Treatment of psoriasis
• Route(s) of administration:
  Oral use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  17/03/2017

Decision

P/0055/2017: EMA decision of 17 March 2017 on the acceptance of a modification of an agreed paediatric investigation plan for tofacitinib (EMEA- 000576-PIP02-11-M04)

AdoptedReference Number: EMA/104672/2017